A guide to immunotherapy for COVID-19
FL van de Veerdonk, E Giamarellos-Bourboulis… - Nature medicine, 2022 - nature.com
Immune dysregulation is an important component of the pathophysiology of COVID-19. A
large body of literature has reported the effect of immune-based therapies in patients with …
large body of literature has reported the effect of immune-based therapies in patients with …
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
MF Osuchowski, MS Winkler, T Skirecki… - The Lancet …, 2021 - thelancet.com
The zoonotic SARS-CoV-2 virus that causes COVID-19 continues to spread worldwide, with
devastating consequences. While the medical community has gained insight into the …
devastating consequences. While the medical community has gained insight into the …
Understanding the pathophysiology of typical acute respiratory distress syndrome and severe COVID-19
Introduction Typical acute respiratory distress syndrome (ARDS) and severe coronavirus-19
(COVID-19) pneumonia share complex pathophysiology, a high mortality rate, and an unmet …
(COVID-19) pneumonia share complex pathophysiology, a high mortality rate, and an unmet …
[HTML][HTML] Rationales and uncertainties for aspirin use in COVID-19: a narrative review
Rationales and uncertainties for aspirin use in COVID-19: a narrative review - PMC Back to
Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …
Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …
Decreased protein C activity, lower ADAMTS13 antigen and free protein S levels accompanied by unchanged thrombin generation potential in hospitalized COVID-19 …
K Wójcik, S Bazan-Socha, N Celejewska-Wójcik… - Thrombosis …, 2023 - Elsevier
Introduction COVID-19 is associated with an increased thromboembolic risk. However, the
mechanisms triggering clot formation in those patients remain unknown. Patients and …
mechanisms triggering clot formation in those patients remain unknown. Patients and …
Antirheumatic Drugs against COVID-19 from the Perspective of Rheumatologists
M Kawazoe, M Kihara, T Nanki - Pharmaceuticals, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19) remains a global threat to humanity. Its pathogenesis
and different phases of disease progression are being elucidated under the pandemic …
and different phases of disease progression are being elucidated under the pandemic …
A 12-hospital prospective evaluation of a clinical decision support prognostic algorithm based on logistic regression as a form of machine learning to facilitate decision …
Objective To prospectively evaluate a logistic regression-based machine learning (ML)
prognostic algorithm implemented in real-time as a clinical decision support (CDS) system …
prognostic algorithm implemented in real-time as a clinical decision support (CDS) system …
Immunouniverse of SARS-CoV-2
D Jiménez, M Torres Arias - Immunological Medicine, 2022 - Taylor & Francis
SARS-CoV-2 virus has become a global health problem that has caused millions of deaths
worldwide. The infection can present with multiple clinical features ranging from …
worldwide. The infection can present with multiple clinical features ranging from …
COVID-19 infection as a new risk factor for penile Mondor disease
K Balawender, A Pliszka, A Surowiec, S Rajda - BMC urology, 2022 - Springer
Abstract Background Penile Mondor disease is a superficial dorsal vein thrombophlebitis of
the penis, which mainly affects young and middle-aged men. It generally manifests as a …
the penis, which mainly affects young and middle-aged men. It generally manifests as a …
Solanum nigrum L. in COVID-19 and post-COVID complications: a propitious candidate
D Sharma, M Joshi, S Apparsundaram… - Molecular and Cellular …, 2023 - Springer
COVID-19 is caused by severe acute respiratory syndrome coronavirus-2, SARS-CoV-2.
COVID-19 has changed the world scenario and caused mortality around the globe. Patients …
COVID-19 has changed the world scenario and caused mortality around the globe. Patients …